Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca announces proposal to close Brixham Environmental Laboratory
-
AstraZeneca initiates phase III clinical programme for selumetinib, a treatment in development for patients with advanced or metastastic non-small-cell lung cancer
-
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability
-
AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostate cancer treatment
-
MedImmune Completes Acquisition of Amplimmune
-
US Appeals Court lifts temporary injunction against Hanmi's 505(b)2 NDA esomeprazole strontium product
-
AstraZeneca welcomes new arrivals as Alderley Park BioHub expands
-
Marketing Authorisation Application for naloxegol accepted by European Medicines Agency
-
Marketing Authorisation Application for olaparib accepted by European Medicines Agency
-
New hypoglycemia and pancreatitis subanalyses from the Onglyza® (saxagliptin) SAVOR cardiovascular outcomes trial presented at the 49th annual meeting of the European Association for the Study of Diabetes (EASD)
Latest articles and press releases
All of our latest press releases and articles are available to explore
